About: Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 16 December 2019

AttributesValues
rdf:type
description
  • wetenschappelijk artikel (nl)
  • article scientifique publié en 2019 (fr)
  • artículu científicu espublizáu n'avientu de 2019 (ast)
  • наукова стаття, опублікована 16 грудня 2019 (uk)
  • scientific article published on 16 December 2019 (en)
publication date
publication date
author name string
author name string
  • Stephen Chan
  • Peter Schmid
  • Melissa Phillips
  • Javier Cortes
  • Elza C de Bruin
  • Yeon Hee Park
  • Jean-Marc Ferrero
  • Nicholas C Turner
  • Duncan Wheatley
  • Matthew Burgess
  • Shah-Jalal Sarker
  • Robert McEwen
  • Brian Dougherty
  • Daniel Stetson
  • László Mangel
  • Aaron Prendergast
  • Gia Nemsadze
  • Hayley Cartwright
  • Jacinta Abraham
  • John Conibear
  • Kelly Mousa
  • Timothy Perren
  • Andrew Foxley
  • Cheryl Lawrence
  • Max McLaughlin-Callan
rdfs:label
  • Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial (en)
  • Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial (nl)
skos:prefLabel
  • Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial (en)
  • Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial (nl)
name
  • Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial (en)
  • Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial (nl)
author
author
title
title
  • Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial (en)
page(s)
page(s)
  • 423-433
instance of
instance of
main subject
main subject
PubMed ID
PubMed ID
PubMed ID
  • 31841354
published in
published in
issue
volume
issue
  • 5
volume
  • 38
DOI
DOI
DOI
  • 10.1200/JCO.19.00368
is about of
is cites work of
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software